Elizabeth Vera

7PUBLICATIONS

59CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 15, 2026

Natural history study of adults with primary central nervous system tumors: Initial results for first 1000 participants.

|Apr 24, 2026

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

|Apr 22, 2026

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

|Mar 09, 2026

The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor population.

Zuena Karim, Kimberly Robins, Orieta Celiku

|Jul 12, 2025

RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice.

Edward K Avila, Anne S Reiner, Terri S Armstrong

|Mar 28, 2025

Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: a scoping review.

Amanda L King, Tamara Vasilj, Diane Cooper

Pageof 2

Frequent Collaborators

Terri S Armstrong

Ying Yuan

Tobias Walbert

Kenneth Aldape

Mark R Gilbert

Byram H Ozer

John de Groot

Jing Wu

Mark R Gilbert

Tito R Mendoza

Frequent Collaborators

Terri S Armstrong

Ying Yuan

Tobias Walbert

Kenneth Aldape